Alteration of biochemical and pathological properties of TDP-43 protein by a lipid mediator, 15-deoxy-Δ12,14-prostaglandin J2

Experimental Neurology

Volumn 222, Issue 2, 2010, Pages 296-303

  Zhang, Hai Xin ^a   Tanji, Kunikazu ^a   Yoshida, Hidemi ^a   Hayakari, Makoto ^b   Shibata, Takahiro ^c   Mori, Fumiaki ^a   Uchida, Koji ^c   Wakabayashi, Koichi ^a  

^a HIROSAKI UNIVERSITY   (Japan)

^b HIROSAKI UNIVERSITY HOSPITAL   (Japan)

^c NAGOYA UNIVERSITY   (Japan)

Author keywords

Amyotrophic lateral sclerosis; Caspase; Frontotemporal lobar degeneration; Prostaglandin; TDP 43

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; TAR DNA BINDING PROTEIN;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL LOBAR DEGENERATION WITH UBIQUITIN POSITIVE INCLUSION; ARTICLE; CELL STRAIN HEK293; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; HELA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; NEUROBLASTOMA CELL; NEUROPATHOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; SOLUBILITY; SPINAL CORD;

AGED; AGED, 80 AND OVER; AMYOTROPHIC LATERAL SCLEROSIS; CELL LINE; CYCLOPENTANES; CYTOPLASM; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; IMMUNOLOGIC FACTORS; MALE; MIDDLE AGED; NEUROBLASTOMA; PROSTAGLANDIN D2; SPINAL CORD; SUBCELLULAR FRACTIONS;

EID: 77549088434     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2010.01.007     Document Type: Article

References (49)

1. Aldini G., Carini M., Vistoli G., Shibata T., Kusano Y., Gamberoni L., Dalle-Donne I., Milzani A., and Uchida K. Identification of actin as a 15-deoxy-Delta12,14-prostaglandin J2 target in neuroblastoma cells: mass spectrometric, computational, and functional approaches to investigate the effect on cytoskeletal derangement. Biochemistry 46 (2007) 2707-2718
2. Amador-Ortiz C., Lin W.L., Ahmed Z., Personett D., Davies P., Duara R., Graff-Radford N.R., Hutton M.L., and Dickson D.W. TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease. Ann. Neurol. 61 (2007) 435-445
3. Arai T., Hasegawa M., Akiyama H., Ikeda K., Nonaka T., Mori H., Mann D., Tsuchiya K., Yoshida M., Hashizume Y., and Oda T. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun. 351 (2006) 602-611
4. Arnold R., Neumann M., and Konig W. Peroxisome proliferator-activated receptor-gamma agonists inhibit respiratory syncytial virus-induced expression of intercellular adhesion molecule-1 in human lung epithelial cells. Immunology 121 (2007) 71-81
5. Atsmon J., Sweetman B.J., Baertschi S.W., Harris T.M., and Roberts Jr. L.J. Formation of thiol conjugates of 9-deoxy-delta 9, delta 12(E)-prostaglandin D2 and delta 12(E)-prostaglandin D2. Biochemistry 29 (1990) 3760-3765
6. Ayala Y.M., Pantano S., D'Ambrogio A., Buratti E., Brindisi A., Marchetti C., Romano M., and Baralle F.E. Human, Drosophila, and C. elegans TDP43: nucleic acid binding properties and splicing regulatory function. J. Mol. Biol. 348 (2005) 575-588
7. Buratti E., and Baralle F.E. Characterization and functional implications of the RNA binding properties of nuclear factor TDP-43, a novel splicing regulator of CFTR exon 9. J. Biol. Chem. 276 (2001) 36337-36343
8. Campo P.A., Das S., Hsiang C.H., Bui T., Samuel C.E., and Straus D.S. Translational regulation of cyclin D1 by 15-deoxy-delta(12,14)-prostaglandin J(2). Cell Growth Differ. 13 (2002) 409-420
9. Clausen J. Proteins in normal cerebrospinal fluid not found in serum. Proc. Soc. Exp. Biol. Med. 107 (1961) 170-172
10. Fionda C., Nappi F., Piccoli M., Frati L., Santoni A., and Cippitelli M. Inhibition of trail gene expression by cyclopentenonic prostaglandin 15-deoxy-delta12,14-prostaglandin J2 in T lymphocytes. Mol. Pharmacol. 72 (2007) 1246-1257
11. Fitzpatrick F.A., and Wynalda M.A. Albumin-catalyzed metabolism of prostaglandin D2. Identification of products formed in vitro. J. Biol. Chem. 258 (1983) 11713-11718
12. Fukushima M. Prostaglandin J2-anti-tumour and anti-viral activities and the mechanisms involved. Eicosanoids 3 (1990) 189-199
13. Geser F., Winton M.J., Kwong L.K., Xu Y., Xie S.X., Igaz L.M., Garruto R.M., Perl D.P., Galasko D., Lee V.M., and Trojanowski J.Q. Pathological TDP-43 in parkinsonism-dementia complex and amyotrophic lateral sclerosis of Guam. Acta Neuropathol. 115 (2008) 133-145
14. Gilroy D.W., Colville-Nash P.R., Willis D., Chivers J., Paul-Clark M.J., and Willoughby D.A. Inducible cyclooxygenase may have anti-inflammatory properties. Nat. Med. 5 (1999) 698-701
15. Hasegawa H., Yamada Y., Komiyama K., Hayashi M., Ishibashi M., Sunazuka T., Izuhara T., Sugahara K., Tsuruda K., Masuda M., Takasu N., Tsukasaki K., Tomonaga M., and Kamihira S. A novel natural compound, a cycloanthranilylproline derivative (Fuligocandin B), sensitizes leukemia cells to apoptosis induced by tumor necrosis factor related apoptosis-inducing ligand (TRAIL) through 15-deoxy-Delta 12, 14 prostaglandin J2 production. Blood 110 (2007) 1664-1674
16. Hasegawa M., Arai T., Akiyama H., Nonaka T., Mori H., Hashimoto T., Yamazaki M., and Oyanagi K. TDP-43 is deposited in the Guam parkinsonism-dementia complex brains. Brain 130 (2007) 1386-1394
17. Higashi S., Iseki E., Yamamoto R., Minegishi M., Hino H., Fujisawa K., Togo T., Katsuse O., Uchikado H., Furukawa Y., Kosaka K., and Arai H. Concurrence of TDP-43, tau and alpha-synuclein pathology in brains of Alzheimer's disease and dementia with Lewy bodies. Brain Res. 1184 (2007) 284-294
18. Honn K.V., and Marnett L.J. Requirement of a reactive alpha, beta-unsaturated carbonyl for inhibition of tumor growth and induction of differentiation by "A" series prostaglandins. Biochem. Biophys. Res. Commun. 129 (1985) 34-40
19. Itoh K., Mochizuki M., Ishii Y., Ishii T., Shibata T., Kawamoto Y., Kelly V., Sekizawa K., Uchida K., and Yamamoto M. Transcription factor Nrf2 regulates inflammation by mediating the effect of 15-deoxy-Delta(12,14)-prostaglandin j(2). Mol. Cell Biol. 24 (2004) 36-45
20. Kamagata C., Tsuji N., Moriai M., Kobayashi D., and Watanabe N. 15-deoxy-Delta(12,14)-prostaglandin J2 inhibits G2-M phase progression in human breast cancer cells via the down-regulation of cyclin B1 and survivin expression. Breast Cancer Res. Treat. 102 (2007) 263-273
21. Kerr B.J., Girolami E.I., Ghasemlou N., Jeong S.Y., and David S. The protective effects of 15-deoxy-delta-(12,14)-prostaglandin J2 in spinal cord injury. Glia 56 (2008) 436-448
22. Kondo M., Shibata T., Kumagai T., Osawa T., Shibata N., Kobayashi M., Sasaki S., Iwata M., Noguchi N., and Uchida K. 15-Deoxy-Delta(12,14)-prostaglandin J(2): the endogenous electrophile that induces neuronal apoptosis. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 7367-7372
23. Kuruvilla A.P., Hochwald G.M., Ghiso J., Castano E.M., Pizzolato M., and Frangione B. Isolation and amino terminal sequence of beta-trace, a novel protein from human cerebrospinal fluid. Brain Res. 565 (1991) 337-340
24. Lee E.B., Lee V.M., Trojanowski J.Q., and Neumann M. TDP-43 immunoreactivity in anoxic, ischemic and neoplastic lesions of the central nervous system. Acta Neuropathol. 115 (2008) 305-311
25. Martin L.J. Neuronal death in amyotrophic lateral sclerosis is apoptosis: possible contribution of a programmed cell death mechanism. J. Neuropathol. Exp. Neurol. 58 (1999) 459-471
26. Mori F., Tanji K., Zhang H.X., Nishihira Y., Tan C.F., Takahashi H., and Wakabayashi K. Maturation process of TDP-43-positive neuronal cytoplasmic inclusions in amyotrophic lateral sclerosis with and without dementia. Acta Neuropathol. 116 (2008) 193-203
27. Nakashima-Yasuda H., Uryu K., Robinson J., Xie S.X., Hurtig H., Duda J.E., Arnold S.E., Siderowf A., Grossman M., Leverenz J.B., Woltjer R., Lopez O.L., Hamilton R., Tsuang D.W., Galasko D., Masliah E., Kaye J., Clark C.M., Montine T.J., Lee V.M., and Trojanowski J.Q. Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases. Acta Neuropathol. 114 (2007) 221-229
28. Narumiya S., Ogorochi T., Nakao K., and Hayaishi O. Prostaglandin D2 in rat brain, spinal cord and pituitary: basal level and regional distribution. Life Sci. 31 (1982) 2093-2103
29. Narumiya S., Ohno K., Fukushima M., and Fujiwara M. Site and mechanism of growth inhibition by prostaglandins. III: distribution and binding of prostaglandin A2 and delta 12-prostaglandin J2 in nuclei. J. Pharmacol. Exp. Ther. 242 (1987) 306-311
30. Neumann M., Sampathu D.M., Kwong L.K., Truax A.C., Micsenyi M.C., Chou T.T., Bruce J., Schuck T., Grossman M., Clark C.M., McCluskey L.F., Miller B.L., Masliah E., Mackenzie I.R., Feldman H., Feiden W., Kretzschmar H.A., Trojanowski J.Q., and Lee V.M. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314 (2006) 130-133
31. Ou S.H., Wu F., Harrich D., Garcia-Martinez L.F., and Gaynor R.B. Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs. J. Virol. 69 (1995) 3584-3596
32. Parker J. Prostaglandin A2 protein interactions and inhibition of cellular proliferation. Prostaglandins 50 (1995) 359-375
33. Pereira M.P., Hurtado O., Cardenas A., Bosca L., Castillo J., Davalos A., Vivancos J., Serena J., Lorenzo P., Lizasoain I., and Moro M.A. Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2 cause potent neuroprotection after experimental stroke through noncompletely overlapping mechanisms. J. Cereb. Blood Flow Metab. 26 (2006) 218-229
34. Probst A., Taylor K.I., and Tolnay M. Hippocampal sclerosis dementia: a reappraisal. Acta Neuropathol. 114 (2007) 335-345
35. Qin C., Burghardt R., Smith R., Wormke M., Stewart J., and Safe S. Peroxisome proliferator-activated receptor gamma agonists induce proteasome-dependent degradation of cyclin D1 and estrogen receptor alpha in MCF-7 breast cancer cells. Cancer Res. 63 (2003) 958-964
36. Rajakariar R., Hilliard M., Lawrence T., Trivedi S., Colville-Nash P., Bellingan G., Fitzgerald D., Yaqoob M.M., and Gilroy D.W. Hematopoietic prostaglandin D2 synthase controls the onset and resolution of acute inflammation through PGD2 and 15-deoxyDelta12 14 PGJ2. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 20979-20984
37. Rohn T.T., Wong S.M., Cotman C.W., and Cribbs D.H. 15-Deoxy-delta12,14-prostaglandin J2, a specific ligand for peroxisome proliferator-activated receptor-gamma, induces neuronal apoptosis. Neuroreport 12 (2001) 839-843
38. Rossi A., Kapahi P., Natoli G., Takahashi T., Chen Y., Karin M., and Santoro M.G. Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase. Nature 403 (2000) 103-108
39. Shibata T., Kondo M., Osawa T., Shibata N., Kobayashi M., and Uchida K. 15-Deoxy-delta 12,14-prostaglandin J2. A prostaglandin D2 metabolite generated during inflammatory processes. J. Biol. Chem. 277 (2002) 10459-10466
40. Straus D.S., Pascual G., Li M., Welch J.S., Ricote M., Hsiang C.H., Sengchanthalangsy L.L., Ghosh G., and Glass C.K. 15-Deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 4844-4849
41. Su J.H., Nichol K.E., Sitch T., Sheu P., Chubb C., Miller B.L., Tomaselli K.J., Kim R.C., and Cotman C.W. DNA damage and activated caspase-3 expression in neurons and astrocytes: evidence for apoptosis in frontotemporal dementia. Exp. Neurol. 163 (2000) 9-19
42. Wang C., Fu M., D'Amico M., Albanese C., Zhou J.N., Brownlee M., Lisanti M.P., Chatterjee V.K., Lazar M.A., and Pestell R.G. Inhibition of cellular proliferation through IkappaB kinase-independent and peroxisome proliferator-activated receptor gamma-dependent repression of cyclin D1. Mol. Cell Biol. 21 (2001) 3057-3070
43. Wang Z., Aris V.M., Ogburn K.D., Soteropoulos P., and Figueiredo-Pereira M.E. Prostaglandin J2 alters pro-survival and pro-death gene expression patterns and 26 S proteasome assembly in human neuroblastoma cells. J. Biol. Chem. 281 (2006) 21377-21386
44. Wang Z., and Figueiredo-Pereira M.E. Inhibition of sequestosome 1/p62 up-regulation prevents aggregation of ubiquitinated proteins induced by prostaglandin J2 without reducing its neurotoxicity. Mol. Cell Neurosci. 29 (2005) 222-231
45. Yagami T., Ueda K., Asakura K., Takasu N., Sakaeda T., Itoh N., Sakaguchi G., Kishino J., Nakazato H., Katsuyama Y., Nagasaki T., Okamura N., Hori Y., Hanasaki K., Arimura A., and Fujimoto M. Novel binding sites of 15-deoxy-Delta12,14-prostaglandin J2 in plasma membranes from primary rat cortical neurons. Exp. Cell Res. 291 (2003) 212-227
46. Zahn M., Mader M., Schmidt B., Bollensen E., and Felgenhauer K. Purification and N-terminal sequence of beta-trace, a protein abundant in human cerebrospinal fluid. Neurosci. Lett. 154 (1993) 93-95
47. Zander T., Kraus J.A., Grommes C., Schlegel U., Feinstein D., Klockgether T., Landreth G., Koenigsknecht J., and Heneka M.T. Induction of apoptosis in human and rat glioma by agonists of the nuclear receptor PPARgamma. J. Neurochem. 81 (2002) 1052-1060
48. Zhang H.X., Tanji K., Mori F., and Wakabayashi K. Epitope mapping of 2E2-D3, a monoclonal antibody directed against human TDP-43. Neurosci. Lett. 434 (2008) 170-174
49. Zhang Y.J., Xu Y.F., Dickey C.A., Buratti E., Baralle F., Bailey R., Pickering-Brown S., Dickson D., and Petrucelli L. Progranulin mediates caspase-dependent cleavage of TAR DNA binding protein-43. J. Neurosci. 27 (2007) 10530-10534